MedPath

BRIMONIDINE TARTRATE

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION REDNESS RELIEVER EYE DROPS

Approved
Approval ID

e81b6e36-492f-67db-de4e-43ac72bf7797

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Aug 27, 2024

Manufacturers
FDA

Walgreens Company

DUNS: 008965063

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

brimonidine tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0363-9960
Application NumberANDA216361
Product Classification
M
Marketing Category
C73584
G
Generic Name
brimonidine tartrate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 27, 2024
FDA Product Classification

INGREDIENTS (9)

BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
CALCIUM CHLORIDEInactive
Code: M4I0D6VV5M
Classification: IACT
BRIMONIDINE TARTRATEActive
Quantity: 0.25 mg in 1 mL
Code: 4S9CL2DY2H
Classification: ACTIB
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
POTASSIUM CHLORIDEInactive
Code: 660YQ98I10
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.